13D/13G Filings - Cambrian BioPharma Inc

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2023-08-04
4:41 pm
Sale
2023-07-31 13G Sensei Biotherapeutics, Inc.
SNSE
Cambrian BioPharma Inc 182,656
14.600%
-79,142decrease
(-30.23%)
Filing
History
2023-02-14
11:36 am
Purchase
2022-12-31 13G Sensei Biotherapeutics, Inc.
SNSE
Cambrian BioPharma Inc 261,798
17.000%
223increase
(+0.09%)
Filing
History
2023-02-13
5:16 pm
Purchase
2022-12-31 13G Sensei Biotherapeutics, Inc.
SNSE
Peyer James 261,798
17.000%
261,798increase
(New Position)
Filing
History
2022-06-10
2:18 pm
Purchase
2021-12-31 13G Sensei Biotherapeutics, Inc.
SNSE
Cambrian BioPharma Inc 261,574
17.100%
261,574increase
(New Position)
Filing
History